SCHEMBL4778106

SCHEMBL4778106

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.65
EGFR P00533 16/20 0.62
KCNH2 Q12809 1/20 0.58
KDR P35968 2/20 0.58
RET P07949 1/20 0.58
KIF5B P33176 1/20 0.58
ERBB2 P04626 1/20 0.57
FLT1 P17948 1/20 0.57
EPHA2 P29317 1/20 0.57
EPHB4 P54760 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29989073 1.00 ABCG2 (0.65) ABCG2EGFRKCNH2KDRRET
SCHEMBL16212241 0.88 EGFR (0.63) ABCG2EGFRKCNH2KDRRET
SCHEMBL4576844 0.87 EGFR (0.52) ABCG2EGFRKCNH2ERBB2
SCHEMBL4576452 0.87 EGFR (0.60) ABCG2EGFRKCNH2
SCHEMBL29719006 0.87 EGFR (0.60) ABCG2EGFRKCNH2
SCHEMBL10100955 0.86 KDR (0.75) EGFRKCNH2KDRRETKIF5B
SCHEMBL158077 0.86 ABCG2 (0.59) ABCG2EGFRKDRRETKIF5B
Hydrochloric Acid SCHEMBL4775089 0.86 EGFR (0.59) ABCG2EGFRKCNH2
SCHEMBL22983644 0.85 EGFR (0.50) ABCG2EGFR
SCHEMBL29718969 0.85 EGFR (0.50) ABCG2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113307797-B Polysubstituted quinazoline compound and application thereof 江南大学 2022-08-09 CN disclosed
CN-113307797-A Polysubstituted quinazoline compound and application thereof 江南大学 2021-08-27 CN disclosed
CN-111848584-A Polysubstituted quinazoline compound and application thereof 江南大学 2020-10-30 CN disclosed
WO-2008002039-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCER CELL HANMI PHARM. CO., LTD. (KR) 2008-01-03 WO disclosed